Pharmaceutical company AstraZeneca PLC, who make diabetes drugs, have applied to get a new drug application passed by the Food and Drug Administration in America. Astra have also submitted the drug to European authorities for marketing clearance.
Both the European Medicines Agency and the US Food and Drug Administration will decide whether the drug Onglyza is suitable for release to people with diabetes . The drug, created with partner Bristol-Myers Squibb is tipped to be a blockbuster by drug analysts.
The two companies have been working together to develop new drugs for type 2 diabetes since January 2007. The drug that may be released is called saxagliptin, Onglyza being the trade name created by the company.
Diabetes company looking for drug approval
Thu, 24 Jul 2008
Recommended links
Diabetes newsletterDiabetes based financial services
Diabetes forum
Diabetes signs and symptoms
Diabetes health issues
Sweeteners vary for managing diabetes
Diabetes ups tuberculosis risk
FDA reconsidering diabetes drug approval process
New FDA drug approvals
EU approval for Novartis diabetes drug
Merck win approval for new diabetes drug
Takeda looking for diabetes drug approval
Diabetes company get Canadian approval
Healthcare professionals question diabetes approval
Approval for 45-minute diabetes treatment
Merck diabetes drug should win US approval
Galvus diabetes drug pending approval in EU
Diabetes drug gets FDA approval
